Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Prophylactic Local Tobramycin Injection Lower Open Fracture Infection Rates?

NCT04964947 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04964947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04964947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Prophylactic Local Tobramycin Injection Lower Open Fracture Infection Rates?
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Completed
Start date
January 10, 2022
Completion date
July 1, 2026
Enrollment
600 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

fractures, open, surgical site infection, wound infection